If life sciences companies address these aspects early, they can successfully plan commercial launches and enable future adaptability.
In brief
- To manage compliance and reduce costs, companies should consider customs and VAT complexities.
- Driven by the COVID-19 pandemic, life sciences companies have focused on increasing supply chain flexibility to reduce future disruption.
- Opportunities exist to yield savings in customs and VAT compliance, specifically when identified early in the supply chain design.
Source EY
Latest Posts in "World"
- Understanding VAT Implications for Borderless Workers: Key Considerations for Global Mobility
- OECD Report 2025: Tax Reforms Target Health Costs, Aging, and Sustainability with New Measures
- 7 Essential Steps for International VAT Registration and Compliance Success
- Global E-Invoicing Trends 2025: Shaping the Future of Tax Compliance
- How Digital Tax Laws Apply to Online Courses
